• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Vigorous, regular physical exercise may slow disease progression in Alzheimer's disease.积极、有规律的体育锻炼可能减缓阿尔茨海默病的疾病进展。
Alzheimers Dement. 2023 Apr;19(4):1592-1597. doi: 10.1002/alz.12946. Epub 2023 Feb 1.
2
A biomarker study in long-lasting amnestic mild cognitive impairment.一项针对持续性遗忘型轻度认知障碍的生物标志物研究。
Alzheimers Res Ther. 2018 Apr 25;10(1):42. doi: 10.1186/s13195-018-0369-8.
3
Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment.诊断测试在预测有或无遗忘型轻度认知障碍的年轻和老年患者向阿尔茨海默病转化中的价值。
J Alzheimers Dis. 2012;29(3):641-8. doi: 10.3233/JAD-2012-111703.
4
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker.18F-FDG-PET与脑脊液生物标志物在疑似阿尔茨海默病且首次生物标志物结果不确定的轻度认知障碍患者中的相互增量价值
J Alzheimers Dis. 2019;72(4):1193-1207. doi: 10.3233/JAD-190539.
5
Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and F-FDG-PET imaging.与 CSF、MRI、淀粉样蛋白和 F-FDG-PET 成像相关的短期认知下降和 MCI 至 AD 痴呆的转化。
Neuroimage Clin. 2019;22:101771. doi: 10.1016/j.nicl.2019.101771. Epub 2019 Mar 13.
6
Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.多参数PET在预测阿尔茨海默病进展中的潜在临床价值
PLoS One. 2016 May 16;11(5):e0154406. doi: 10.1371/journal.pone.0154406. eCollection 2016.
7
Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.18F-FDG-PET 和磁共振成像对预测轻度认知障碍向阿尔茨海默病转化的价值的长期研究:一项多中心研究。
J Alzheimers Dis. 2017;60(3):877-887. doi: 10.3233/JAD-170395.
8
Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.经正电子发射断层扫描(PET)生物标志物检测,诊断为阿尔茨海默病所致轻度认知障碍,伴有β淀粉样蛋白和神经元功能障碍。
PLoS One. 2013 Jun 14;8(6):e66877. doi: 10.1371/journal.pone.0066877. Print 2013.
9
Neuropsychological Testing Predicts Cerebrospinal Fluid Amyloid-β in Mild Cognitive Impairment.神经心理学测试可预测轻度认知障碍患者脑脊液中的淀粉样蛋白β。
J Alzheimers Dis. 2015;46(4):901-12. doi: 10.3233/JAD-142943.
10
Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.与可能的遗忘型轻度认知障碍-存储亚型内神经影像学生物标志物相关的认知综合领域得分
J Alzheimers Dis. 2017;57(2):447-459. doi: 10.3233/JAD-161223.

引用本文的文献

1
Neurophysiological mechanisms underlying cardiovascular adaptations to exercise: A narrative review.运动中心血管适应性的神经生理机制:一篇综述
Physiol Rep. 2025 Jul;13(13):e70439. doi: 10.14814/phy2.70439.
2
Factors Affecting Resilience and Prevention of Alzheimer's Disease and Related Dementias.影响阿尔茨海默病和相关痴呆症的韧性和预防的因素。
Ann Neurol. 2024 Oct;96(4):633-649. doi: 10.1002/ana.27055. Epub 2024 Aug 17.
3
A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer's disease.阿尔茨海默病诊断与治疗的精准医学方法操作指南。
Front Aging Neurosci. 2023 Aug 17;15:1213968. doi: 10.3389/fnagi.2023.1213968. eCollection 2023.
4
Alzheimer's Disease Treatment: The Search for a Breakthrough.阿尔茨海默病治疗:寻求突破。
Medicina (Kaunas). 2023 Jun 4;59(6):1084. doi: 10.3390/medicina59061084.

本文引用的文献

1
Association of Daily Step Count and Intensity With Incident Dementia in 78 430 Adults Living in the UK.在英国,78430 名成年人中,每日步数和强度与痴呆症发病的相关性。
JAMA Neurol. 2022 Oct 1;79(10):1059-1063. doi: 10.1001/jamaneurol.2022.2672.
2
Effect of Physical Exercise on Cognitive Function of Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.体育锻炼对阿尔茨海默病患者认知功能的影响:一项随机对照试验的系统评价和荟萃分析
Front Psychiatry. 2022 Jun 16;13:927128. doi: 10.3389/fpsyt.2022.927128. eCollection 2022.
3
Exercise interventions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials.阿尔茨海默病的运动干预:随机对照试验的系统评价和荟萃分析
Ageing Res Rev. 2021 Dec;72:101479. doi: 10.1016/j.arr.2021.101479. Epub 2021 Sep 30.
4
Alzheimer's disease.阿尔茨海默病。
Lancet. 2021 Apr 24;397(10284):1577-1590. doi: 10.1016/S0140-6736(20)32205-4. Epub 2021 Mar 2.
5
Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial.抗病毒治疗:伐昔洛韦治疗阿尔茨海默病(VALAD)试验:一项随机、双盲、安慰剂对照治疗试验的方案。
BMJ Open. 2020 Feb 6;10(2):e032112. doi: 10.1136/bmjopen-2019-032112.
6
Three months of multimodal training contributes to mobility and executive function in elderly individuals with mild cognitive impairment, but not in those with Alzheimer's disease: A randomized controlled trial.三个月的多模式训练有助于改善轻度认知障碍老年人的运动能力和执行功能,但对阿尔茨海默病患者无效:一项随机对照试验。
Maturitas. 2019 Aug;126:28-33. doi: 10.1016/j.maturitas.2019.04.217. Epub 2019 Apr 27.
7
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.阿尔茨海默病的临床前、前驱和痴呆阶段的持续时间与年龄、性别和 APOE 基因型有关。
Alzheimers Dement. 2019 Jul;15(7):888-898. doi: 10.1016/j.jalz.2019.04.001. Epub 2019 Jun 1.
8
Dementia awareness and risk perception in middle-aged and older individuals: baseline results of the MijnBreincoach survey on the association between lifestyle and brain health.中老年人群的痴呆症认知和风险感知:生活方式与大脑健康关联的 MijnBreincoach 调查的基线结果。
BMC Public Health. 2019 Jun 3;19(1):678. doi: 10.1186/s12889-019-7010-z.
9
Hippocampal gene expression patterns linked to late-life physical activity oppose age and AD-related transcriptional decline.与晚年体力活动相关的海马体基因表达模式与年龄和 AD 相关的转录水平下降相反。
Neurobiol Aging. 2019 Jun;78:142-154. doi: 10.1016/j.neurobiolaging.2019.02.012. Epub 2019 Feb 20.
10
Exercise-induced brain-derived neurotrophic factor expression: Therapeutic implications for Alzheimer's dementia.运动诱导的脑源性神经营养因子表达:对阿尔茨海默病痴呆的治疗意义。
Ageing Res Rev. 2018 Dec;48:109-121. doi: 10.1016/j.arr.2018.10.002. Epub 2018 Oct 13.

积极、有规律的体育锻炼可能减缓阿尔茨海默病的疾病进展。

Vigorous, regular physical exercise may slow disease progression in Alzheimer's disease.

机构信息

Area Brain Aging and Mental Health, Department of Psychiatry, Columbia University Irving Medical Center, New York, New York, USA.

The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, USA.

出版信息

Alzheimers Dement. 2023 Apr;19(4):1592-1597. doi: 10.1002/alz.12946. Epub 2023 Feb 1.

DOI:10.1002/alz.12946
PMID:36722738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10101862/
Abstract

INTRODUCTION

Mild to moderate exercise may decrease Alzheimer's disease (AD) risk, but the effects of vigorous, regular physical exercise remain unclear.

METHODS

Two patients with initial diagnoses of amnestic mild cognitive impairment (MCI) demonstrated positive AD biomarkers throughout 16 and 8 years of follow-up, with final diagnoses of mild AD and amnestic MCI, respectively.

RESULTS

Patient 1 was diagnosed with amnestic MCI at age 64. Neuropsychological testing, magnetic resonance imaging (MRI), fluorodeoxyglucose-positron emission tomography (FDG-PET), amyloid imaging PET, and cerebrospinal fluid (CSF) biomarkers during follow-ups remained consistent with AD. By age 80, progression was minimal with Montreal Cognitive Assessment (MoCA) 26 of 30. Patient 2 was diagnosed with amnestic MCI at age 72. Neuropsychological testing, MRI, FDG-PET, and amyloid imaging PET during follow-ups remained consistent with AD. At age 80, MoCA was 27 of 30 with no clinical progression. Both patients regularly performed vigorous, regular exercise that increased after retirement/work reduction.

DISCUSSION

Vigorous, regular exercise may slow disease progression in biomarker-positive amnestic MCI and mild AD.

摘要

简介

适度到剧烈的运动可能会降低阿尔茨海默病(AD)的风险,但剧烈、有规律的体育锻炼的效果仍不清楚。

方法

两名患者最初被诊断为遗忘型轻度认知障碍(MCI),在 16 年和 8 年的随访中均表现出 AD 的阳性生物标志物,最终分别被诊断为轻度 AD 和遗忘型 MCI。

结果

患者 1 于 64 岁时被诊断为遗忘型 MCI。神经心理学测试、磁共振成像(MRI)、氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)、淀粉样蛋白成像 PET 和脑脊液(CSF)生物标志物在随访中均与 AD 一致。到 80 岁时,蒙特利尔认知评估(MoCA)得分为 30 分中的 26 分,进展甚微。患者 2 于 72 岁时被诊断为遗忘型 MCI。神经心理学测试、MRI、FDG-PET 和淀粉样蛋白成像 PET 在随访中均与 AD 一致。到 80 岁时,MoCA 得分为 30 分中的 27 分,无临床进展。两名患者均定期进行剧烈、有规律的运动,退休/减少工作后运动量增加。

讨论

剧烈、有规律的运动可能会减缓生物标志物阳性的遗忘型 MCI 和轻度 AD 的疾病进展。